Top compounds associated with response to OR11A1


Feature Type Standardized
Nominal ANOVA
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.017 0.7
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.013 0.7
mRNA Vorinostat gCSI pan-cancer AAC -0.02 0.7
mRNA UNC0321 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA BRD-K48334597 CTRPv2 pan-cancer AAC -0.029 0.7
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
mRNA Bosutinib CTRPv2 pan-cancer AAC 0.014 0.7
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
Download CSV